Additionally, when looking at late effects of mTOR activity, both human and experimental studies indicate a direct and indirect connection between mTOR hyperactivity and formation of abnormally hyperphosphorylated Tau protein, which is associated with Alzheimer’s disease [43,44,45]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.